{"id":"W2176057383","doi":"10.1089/152581603322448178","title":"Immunostimulatory Oligonucleotides: Ready for Immunotherapy Prime Time!","year":2003,"lang":"en","type":"review","venue":"Journal of Hematotherapy & Stem Cell Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Immunotherapy; Oligonucleotide; Cancer research; Cancer immunotherapy; Computational biology; Medicine; Oncology; Biology; Immunology; Immune system; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.009871723,0.001207658,0.005076773,0.002103921,0.0008709115,0.0002207207,0.002418654,0.001730122,0.002106398],"category_scores_gemma":[0.00009406968,0.0009011265,0.002763997,0.0009350483,0.0007410948,0.0003465922,0.000113161,0.003323567,0.001770386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006758378,"about_ca_system_score_gemma":0.003111573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001222698,"about_ca_topic_score_gemma":3.440952e-7,"domain_scores_codex":[0.9879264,0.005332953,0.003623187,0.0007646599,0.0005444303,0.001808433],"domain_scores_gemma":[0.9877821,0.006248866,0.002634405,0.001647911,0.001572806,0.0001139485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00282317,0.001035289,0.000001710413,0.00472355,0.0042317,0.0000556634,0.0005439954,9.766308e-7,0.0412472,0.000122735,0.02972207,0.9154919],"study_design_scores_gemma":[0.004419175,0.002691477,0.000001303182,0.007019265,0.0003065117,0.001770156,0.0001862502,4.054182e-7,0.01203772,0.00006561623,0.970703,0.0007991202],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003249678,0.9938158,0.0001330707,0.00004000073,0.001433734,0.003088708,0.0001067491,0.00005362338,0.001003337],"genre_scores_gemma":[0.00002793562,0.9305943,0.0003241121,0.0000783253,0.0001572457,0.0001846591,0.00006426908,0.0004547432,0.06811444],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9409809,"threshold_uncertainty_score":0.9995658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1173667501312164,"score_gpt":0.4080249827107963,"score_spread":0.2906582325795799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}